UBS Group
STLNW

UBS Group’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

UBS Group’s Portfolio STLNW Stock Details STLNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,670
Closed -$187 – 10931
2025
Q2 		$187 Buy
3,670
+649
+21% +$41 ﹤0.01% 9937
2025
Q1 		$82 Sell
3,021
-85
-3% -$2 ﹤0.01% 9966
2024
Q4 		$16 Sell
3,106
-2,977
-49% -$46 ﹤0.01% 9787
2024
Q3 		$122 Sell
6,083
-2,706
-31% -$54 ﹤0.01% 9138
2024
Q2 		$229 Buy
+8,789
New +$678 ﹤0.01% 9058
2023
Q4 		– Sell
-1,034
Closed -$88 – 9891
2023
Q3 		$88 Buy
+1,034
New +$84 ﹤0.01% 8916
2023
Q1 		– Sell
-610
Closed -$67 – 10378
2022
Q4 		$67 Sell
610
-4,889
-89% -$1.59K ﹤0.01% 10448
2022
Q3 		$3K Buy
5,499
+25
+0.5% +$17 ﹤0.01% 9587
2022
Q2 		$3K Buy
5,474
+1,000
+22% +$920 ﹤0.01% 9368
2022
Q1 		$5K Buy
4,474
+102
+2% +$93 ﹤0.01% 9169
2021
Q4 		$3K Buy
+4,372
New +$5.41K ﹤0.01% 9696

Other funds holding STLNW

OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
FL
FreeGulliver LLC New Orleans, Louisiana $237M AUM 21.92% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

UBS Group's STLNW Position: Q3 2025 in Review

UBS Group sold out of Starling Oncology, Inc. Warrant (STLNW) in Q3 2025, closing a stake of 3,670 shares — an estimated $187 sold.

UBS Group first reported a position in STLNW in Q4 2021 and held it in 11 quarters. The position peaked at $5K in Q1 2022. 12 funds tracked by Wall St. Rank hold STLNW as of Q3 2025.

  • UBS Group reported no remaining Starling Oncology, Inc. Warrant position as of Q3 2025 after selling out during the quarter.
  • UBS Group sold 3,670 Starling Oncology, Inc. Warrant shares in Q3 2025, an estimated $187.
  • UBS Group first reported a position in Starling Oncology, Inc. Warrant in Q4 2021 and held it in 11 quarters.
  • UBS Group's Starling Oncology, Inc. Warrant position peaked at $5K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q3 2025.

Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.